The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran-Reference-Cited by-同舟云学术

The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran

Published:2019-07-31 Issue:2 Volume:27 Page:627-634
ISSN:2008-2231
Container-title:DARU Journal of Pharmaceutical Sciences
language:en
Short-container-title:DARU J Pharm Sci

Author:

Amirsadri Mohammadreza^ORCID,Mousavi Sarah,Karimipour Ali

Publisher

Springer Science and Business Media LLC

Subject

Applied Mathematics,General Mathematics

Link

http://link.springer.com/content/pdf/10.1007/s40199-019-00292-1.pdf

Reference28 articles.

1. Tagalakis V, Patenaude V, Kahn SR, Suissa S. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE study cohort. Am J Med. 2013;126(9):832. e13–21.

2. Blann A. Deep vein thrombosis and pulmonary embolism: a guide for practitioners: M&K Update Ltd. Cumbria. 2015.

3. Piazza G, Hohlfelder B, Goldhaber SZ. Handbook for Venous Thromboembolism: Springer; 2015.

4. Anderson FA Jr, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23_suppl_1):I-9–I-16.

5. Laryea J, Champagne B. Venous thromboembolism prophylaxis. Clin Colon Rectal Surg. 2013;26(03):153–9.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Venous thromboembolism prevention program implementation in a community oncology practice: a cohort study;The Lancet Regional Health - Americas;2024-10

2. Cancer-Associated Thrombosis: Epidemiology, Pathophysiological Mechanisms, Treatment, and Risk Assessment;Clinical Medicine Insights: Oncology;2023-01

3. Implementing guidelines to prevent cancer associated thrombosis: how can we do better?;Research and Practice in Thrombosis and Haemostasis;2023-01

4. Complexation of mercaptopurine anticancer drug with an iron-doped fullerene cage: DFT assessments of drug delivery approach;Physics Letters A;2022-10

5. A C19Ti Cage vehicle for the drug delivery of purinethol Anticancer: Computational assessments;Computational and Theoretical Chemistry;2022-08